| Identification | Back Directory | [Name]
TRANS-RESVERATROL 4'-O-BETA-D-GLUCURONIDE | [CAS]
38963-95-0 | [Synonyms]
Resveratroloside
Resveratrol 4'-Glucoside
Resveratrol 4′-O-glucopyranoside
Resveratrol -4'-o-beta-d-glucuronide
Resveratrol 4'-O-beta-D-glucopyranoside
TRANS-RESVERATROL 4'-O-BETA-D-GLUCURONIDE
trans-Resveratrol 4-O-b-D-glucopyranoside
trans-Resveratrol 4'-O-β-D-glucopyranoside
3,4',5-Trihydroxystilbene 4'-mono-beta-D-glycopyranoside
β-D-Glucopyranoside, 4-[(1E)-2-(3,5-dihydroxyphenyl)ethenyl]phenyl
4-[(1E)-2-(3,5-Dihydroxyphenyl)ethenyl]phenyl beta-D-glucopyranoside
(2S,3R,4S,5S,6R)-2-[4-[(E)-2-(3,5-dihydroxyphenyl)ethenyl]phenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol | [Molecular Formula]
C20H22O8 | [MDL Number]
MFCD08063732 | [MOL File]
38963-95-0.mol | [Molecular Weight]
390.39 |
| Hazard Information | Back Directory | [Uses]
Resveratroloside is a compound that shows cancer-chemopreventive and antioxidative activity through study. It is due to being a derivative of Resveratrol (R150000) which is a minor constituent of wine
, correlated with serum lipid reduction and inhibition of platelet aggregation. Resveratrol is a specific inhibitor of COX-1, and it also inhibits the hydroperoxidase activity of COX-1. It has been s
hown to inhibit events associated with tumor initiation, promotion and progression. |
|
|